IMMX
Immix Biopharma, Inc.Company with tickers: IMMX
CIK
1873835
CUSIP
45258H106
Shares Outstanding
71,189,951
Website
https://www.immixbio.com
Investor Relations
https://immixbio.com/investors/
13F Activity (30d)
22 filings
22 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | — | ||||
| Net Income | — | ||||
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |